Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Mauritius.
Press releases published on October 22, 2025
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
BROSSARD, Quebec, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence …
NewHydrogen to Release a Special Report on October 27, 2025
The Company will reveal a massive source of heat for its novel ThermoLoop™ heat-based water-splitting system SANTA CLARITA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB:NEWH), the developer of ThermoLoop™, a breakthrough technology …
STACK Infrastructure Secures ¥39.7 Billion in Green Financing to Advance Development of Tokyo Campus
SINGAPORE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to some of the world’s most innovative companies and a leading global developer and operator of data centers, today announced the successful …
New Benevity Impact Labs Research Reveals a Confidence Gap Among Global Grantmakers
CALGARY, Alberta, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Benevity Inc., the global provider of social impact software, today announced the release of a first-of-its-kind research report exploring the state of corporate grantmaking around the world. This latest …
AlphaTON Capital Joins Blockchain Game Alliance (BGA)
Geneva, Switzerland , Oct. 22, 2025 (GLOBE NEWSWIRE) -- “1 Billion Players. One Tap to Play.” AlphaTON backs gaming where distribution already lives—inside Telegram—pairing funding, launch support, and partner access for BGA studios. AlphaTON Capital ( …
I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025
Updated Phase 1 givastomig monotherapy data show an impressive 18% ORR in metastatic gastric cancer patients who had received at least two prior lines of therapy. Responses were observed over a dose range from 5 mg/kg Q2W up to 18 mg/kg Q3W No differences …
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data for …
Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets
– FMC-376 demonstrated robust anti-tumor activity across preclinical models and led to deeper inhibition of KRAS downstream pathways compared to sotorasib – – FMC-220 potently and selectively restored p53 tumor suppressor function and delivered tumor …
Ainekko Launches AI Foundry, Bringing Open-Source Principles and ‘Do-Ocracy’ to AI Hardware
SANTA CLARA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (RISC-V Summit) — Ainekko, a startup pioneering open, software-defined AI infrastructure, today made public the launch of AI Foundry, an open-source platform designed to make advanced hardware and …
Assembly Software Achieves SOC 2 Type II Compliance, Demonstrating Unmatched Commitment to Data Security and Trust
CORAL GABLES, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Assembly Software, a leading provider of AI-powered legal technology and cloud-based solutions, today announced SOC 2 Type II compliance for its Neos platform and NeosAI services, following a …
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the AACR has published online the company’s abstract for …
Darktrace Celebrates Unsung Cybersecurity Heroes with Support of Actor, Writer and Director Clark Gregg
Cambridge, UK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Darktrace, a global leader in AI for cybersecurity, today launched the next phase of its global ‘Defend Beyond™’ campaign in partnership with actor Clark Gregg to celebrate the unseen heroes safeguarding the …
Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch …
AI-powered Co-parenting App BestInterest Launches Solo Mode with Calling — the First AI-Powered Co-Parenting App Offering Safe Digital Separation for High-Conflict Parents
San Francisco, CA , Oct. 22, 2025 (GLOBE NEWSWIRE) -- BestInterest, the pioneering AI-powered co-parenting app for safer communication, has unveiled its latest breakthrough feature, Solo Mode with Calling. This innovative addition empowers parents to …
La planta de productos farmacéuticos estériles de Curia es nombrada “Fabricante del Año” en Massachusetts
ALBANY, Nueva York, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder en investigación, desarrollo y fabricación por contrato (CDMO), anunció hoy que su planta de productos farmacéuticos estériles en Burlington, MA ha …
Curias Anlage für sterile Arzneimittel als Hersteller des Jahres in Massachusetts ausgezeichnet
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute bekannt, dass seine Anlage für sterile Arzneimittel in Burlington, Massachusetts, vom …
L'usine de médicaments stériles Curia nommée fabricant de l'année dans le Massachusetts
ALBANY, N.Y., 22 oct. 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation leader dans la recherche, le développement et la fabrication sous contrat, a annoncé aujourd'hui que son usine de produits pharmaceutiques stériles de Burlington, …
מפעל מוצרי התרופות הסטרילי של Curia זכה בתואר יצרן השנה במסצ'וסטס
אולבני, ניו יורק, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (קוריה), ארגון מוביל למחקר, פיתוח וייצור לפי חוזים, הודיע היום כי מפעל מוצרי התרופות הסטריליות שלו בברלינגטון, מסצ'וסטס זכה בתואר "יצרן השנה" על ידי שדולת הייצור המחוקקת של מסצ'וסטס. …
Fasilitas Produk Obat Steril Curia Dinobatkan sebagai Produsen Terbaik Tahun Ini di Massachusetts
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), perusahaan penelitian, pengembangan, dan manufaktur terkemuka berbasis kontrak hari ini mengumumkan bahwa fasilitas produksi obat sterilnya di Burlington, Massachusetts, telah …